147 related articles for article (PubMed ID: 6385738)
1. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors.
Sixsmith DG; Watkins WM; Chulay JD; Spencer HC
Am J Trop Med Hyg; 1984 Sep; 33(5):772-6. PubMed ID: 6385738
[TBL] [Abstract][Full Text] [Related]
2. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
Basco LK; Le Bras J
Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
4. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
Watkins WM; Sixsmith DG; Chulay JD
Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
[TBL] [Abstract][Full Text] [Related]
5. In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies.
Bhasin VK; Nair L
Jpn J Med Sci Biol; 1996 Feb; 49(1):1-14. PubMed ID: 8799803
[TBL] [Abstract][Full Text] [Related]
6. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
Foote SJ; Galatis D; Cowman AF
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3014-7. PubMed ID: 2183221
[TBL] [Abstract][Full Text] [Related]
7. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya.
Spencer HC; Watkins WW; Sixsmith DG; Koech DK
Trans R Soc Trop Med Hyg; 1986; 80(2):201-3. PubMed ID: 3538522
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum.
Basco LK; Ramiliarisoa O; Le Bras J
Am J Trop Med Hyg; 1994 Feb; 50(2):193-9. PubMed ID: 8116812
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
Hekmat-Nejad M; Rathod PK
Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
Peterson DS; Milhous WK; Wellems TE
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine.
Gyang FN; Peterson DS; Wellems TE
Exp Parasitol; 1992 Jun; 74(4):470-2. PubMed ID: 1592095
[No Abstract] [Full Text] [Related]
12. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
Basco LK; Eldin de Pécoulas P; Wilson CM; Le Bras J; Mazabraud A
Mol Biochem Parasitol; 1995 Jan; 69(1):135-8. PubMed ID: 7723784
[No Abstract] [Full Text] [Related]
13. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
[TBL] [Abstract][Full Text] [Related]
14. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions].
Ndounga M; Basco LK; Ringwald P
Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.
Chulay JD; Watkins WM; Sixsmith DG
Am J Trop Med Hyg; 1984 May; 33(3):325-30. PubMed ID: 6375404
[TBL] [Abstract][Full Text] [Related]
16. Concomitant resistance to pyrimethamine and cycloguanil of chloroquine-resistant falciparum malaria from East Africa: an in vitro study of 12 isolates.
Schapira A
Trans R Soc Trop Med Hyg; 1984; 78(3):359-62. PubMed ID: 6380024
[TBL] [Abstract][Full Text] [Related]
17. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
Fidock DA; Nomura T; Wellems TE
Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
[TBL] [Abstract][Full Text] [Related]
18. Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.
Rastelli G; Sirawaraporn W; Sompornpisut P; Vilaivan T; Kamchonwongpaisan S; Quarrell R; Lowe G; Thebtaranonth Y; Yuthavong Y
Bioorg Med Chem; 2000 May; 8(5):1117-28. PubMed ID: 10882022
[TBL] [Abstract][Full Text] [Related]
19. Altered dihydrofolate reductase in pyrimethamine-resistant Plasmodium falciparum.
Walter RD
Mol Biochem Parasitol; 1986 Apr; 19(1):61-6. PubMed ID: 3520313
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
